Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Connection

Andres Henao Martinez to Candida

This is a "connection" page, showing publications Andres Henao Martinez has written about Candida.

 
Connection Strength
 
 
 
1.186
 
  1. Thompson Iii GR, Chastain DB, Ferraz C, Alhayek S, Salinas JL, Sillau S, Stenehjem EA, Henao-Martínez AF. Mortality patterns in candidemia: Insights from a multispecies analysis using a global research network. Med Mycol. 2024 Dec 27; 63(1).
    View in: PubMed
    Score: 0.846
  2. Campa I, Studebaker M, Henao-Martínez AF, Krsak M, Chastain DB. Clinical characteristics, antifungal exposure, and 90-day mortality of PCR-identified candidemia according to presumed species-level fluconazole susceptibility. Med Mycol. 2026 Aug 05; 64(8).
    View in: PubMed
    Score: 0.236
  3. Endashaw M, Dykes A, Clark R, Warrayat L, Hodges MJ, Deng S, Chen X, Henao-Martínez AF, Chastain DB. Impact of COVID-19 on candidemia: Risk factors and outcomes in a southeastern US cohort. Med Mycol. 2025 Nov 04; 63(11).
    View in: PubMed
    Score: 0.056
  4. Chastain DB, White BP, Tu PJ, Chan S, Jackson BT, Kubbs KA, Bandali A, McDougal S, Henao-Martínez AF, Cluck DB. Candidemia in Adult Patients in the ICU: A Reappraisal of Susceptibility Testing and Antifungal Therapy. Ann Pharmacother. 2024 03; 58(3):305-321.
    View in: PubMed
    Score: 0.047
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)